Anteilseigner
Decheng Capital LLC (12,77 %) Frazier Life Sciences Management LP (9,20 %) Avoro Capital Advisor LLC (8,81 %) BlackRock Fund Advisors (4,77 %) T. Rowe Price Associates, Inc. (Investment Management) (4,62 %) SSgA Funds Management, Inc. (4,34 %) Cormorant Asset Management LP (4,12 %) OrbiMed Advisors Private Equity (4,09 %) Alpine Bioventures, GP, LLC (4,01 %) The Vanguard Group, Inc. (4,00 %) Lynx1 Capital Management LP (3,44 %) Paradigm BioCapital Advisors LP (3,24 %) Darwin Global Management Ltd. (3,02 %) Commodore Capital LP (2,10 %) Octagon Capital Advisors LP (1,89 %) Avidity Partners Management LP (1,79 %) Great Point Partners LLC (1,72 %) Franklin Advisers, Inc. (1,67 %) Geode Capital Management LLC (1,39 %) Morgan Stanley & Co. LLC (1,06 %)
Kontakt
ALPINE IMMUNE SCIENCES INC.